Apolipoproteins in human amniotic fluid: concentrations, isoforms and polymorphism. 1989

A Steinmetz, and M Sefraoui, and E Scheffler, and P Czekelius, and A Barkia, and J M Bard, and H J Parra, and J C Fruchart, and H Kaffarnik
Zentrum Innere Medizin, Institut Pasteur de Lille, France.

Apolipoproteins were determined in 50 human amniotic fluids obtained by amniocentesis during weeks 16 and 22 (n = 26) or 33 and 41 (n = 24) of gestation. Whereas apo A-I, A-II, A-IV, and E were identified at levels of 1, 0.7, 0.8 and 1% of normal human adult plasma, respectively, apo B levels were only 0.04% of plasma concentration and apo C-III levels were below the detection limits of the assay. Amniotic fluid levels of apo A-II, A-IV and E did not differ between early and late stages of pregnancy, but levels of apo B decreased and apo A-I increased significantly in late pregnancy. Isofocusing showed apo A-I, A-II and A-IV in identical positions as compared to human adult plasma. Furthermore the known genetic polymorphism of apo A-IV was detectable. Individuals heterozygous, for the variant form apo A-IV-2, showing the phenotype apo A-IV (2-1), had significantly higher levels of apo A-I and A-II as compared to the common phenotype apo A-IV (1-1). We conclude that human amniotic fluid contains the major plasma apolipoproteins at about 1% of plasma levels with the exception of apo B which shows a level at an order of magnitude less than high-density lipoprotein apoproteins in comparison to their plasma counterparts.

UI MeSH Term Description Entries
D007525 Isoelectric Focusing Electrophoresis in which a pH gradient is established in a gel medium and proteins migrate until they reach the site (or focus) at which the pH is equal to their isoelectric point. Electrofocusing,Focusing, Isoelectric
D011110 Polymorphism, Genetic The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level. Gene Polymorphism,Genetic Polymorphism,Polymorphism (Genetics),Genetic Polymorphisms,Gene Polymorphisms,Polymorphism, Gene,Polymorphisms (Genetics),Polymorphisms, Gene,Polymorphisms, Genetic
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000653 Amniotic Fluid A clear, yellowish liquid that envelopes the FETUS inside the sac of AMNION. In the first trimester, it is likely a transudate of maternal or fetal plasma. In the second trimester, amniotic fluid derives primarily from fetal lung and kidney. Cells or substances in this fluid can be removed for prenatal diagnostic tests (AMNIOCENTESIS). Amniotic Fluid Index,Amniotic Fluid Indices,Amniotic Fluids,Fluid Index, Amniotic,Fluid Indices, Amniotic,Fluid, Amniotic,Fluids, Amniotic,Index, Amniotic Fluid,Indices, Amniotic Fluid
D001053 Apolipoproteins Protein components on the surface of LIPOPROTEINS. They form a layer surrounding the hydrophobic lipid core. There are several classes of apolipoproteins with each playing a different role in lipid transport and LIPID METABOLISM. These proteins are synthesized mainly in the LIVER and the INTESTINES. Apolipoprotein
D001054 Apolipoproteins A Structural proteins of the alpha-lipoproteins (HIGH DENSITY LIPOPROTEINS), including APOLIPOPROTEIN A-I and APOLIPOPROTEIN A-II. They can modulate the activity of LECITHIN CHOLESTEROL ACYLTRANSFERASE. These apolipoproteins are low in atherosclerotic patients. They are either absent or present in extremely low plasma concentration in TANGIER DISEASE. Apo-A,ApoA
D001055 Apolipoproteins B Major structural proteins of triacylglycerol-rich LIPOPROTEINS. There are two forms, apolipoprotein B-100 and apolipoprotein B-48, both derived from a single gene. ApoB-100 expressed in the liver is found in low-density lipoproteins (LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL). ApoB-48 expressed in the intestine is found in CHYLOMICRONS. They are important in the biosynthesis, transport, and metabolism of triacylglycerol-rich lipoproteins. Plasma Apo-B levels are high in atherosclerotic patients but non-detectable in ABETALIPOPROTEINEMIA. Apo-B,Apo B,ApoB,Apoprotein (B),Apoproteins B
D015151 Immunoblotting Immunologic method used for detecting or quantifying immunoreactive substances. The substance is identified by first immobilizing it by blotting onto a membrane and then tagging it with labeled antibodies. Dot Immunoblotting,Electroimmunoblotting,Immunoelectroblotting,Reverse Immunoblotting,Immunoblotting, Dot,Immunoblotting, Reverse,Dot Immunoblottings,Electroimmunoblottings,Immunoblottings,Immunoblottings, Dot,Immunoblottings, Reverse,Immunoelectroblottings,Reverse Immunoblottings

Related Publications

A Steinmetz, and M Sefraoui, and E Scheffler, and P Czekelius, and A Barkia, and J M Bard, and H J Parra, and J C Fruchart, and H Kaffarnik
April 1981, Prenatal diagnosis,
A Steinmetz, and M Sefraoui, and E Scheffler, and P Czekelius, and A Barkia, and J M Bard, and H J Parra, and J C Fruchart, and H Kaffarnik
July 1978, Obstetrics and gynecology,
A Steinmetz, and M Sefraoui, and E Scheffler, and P Czekelius, and A Barkia, and J M Bard, and H J Parra, and J C Fruchart, and H Kaffarnik
February 1979, Clinica chimica acta; international journal of clinical chemistry,
A Steinmetz, and M Sefraoui, and E Scheffler, and P Czekelius, and A Barkia, and J M Bard, and H J Parra, and J C Fruchart, and H Kaffarnik
March 1980, American journal of obstetrics and gynecology,
A Steinmetz, and M Sefraoui, and E Scheffler, and P Czekelius, and A Barkia, and J M Bard, and H J Parra, and J C Fruchart, and H Kaffarnik
September 1979, Proceedings of the National Academy of Sciences of the United States of America,
A Steinmetz, and M Sefraoui, and E Scheffler, and P Czekelius, and A Barkia, and J M Bard, and H J Parra, and J C Fruchart, and H Kaffarnik
February 2012, The Science of the total environment,
A Steinmetz, and M Sefraoui, and E Scheffler, and P Czekelius, and A Barkia, and J M Bard, and H J Parra, and J C Fruchart, and H Kaffarnik
January 1994, FEBS letters,
A Steinmetz, and M Sefraoui, and E Scheffler, and P Czekelius, and A Barkia, and J M Bard, and H J Parra, and J C Fruchart, and H Kaffarnik
January 1988, American journal of perinatology,
A Steinmetz, and M Sefraoui, and E Scheffler, and P Czekelius, and A Barkia, and J M Bard, and H J Parra, and J C Fruchart, and H Kaffarnik
April 1981, Clinica chimica acta; international journal of clinical chemistry,
A Steinmetz, and M Sefraoui, and E Scheffler, and P Czekelius, and A Barkia, and J M Bard, and H J Parra, and J C Fruchart, and H Kaffarnik
January 1991, Nihon Sanka Fujinka Gakkai zasshi,
Copied contents to your clipboard!